Home \ Information Center \ Guidance Documents \ Guideline on Risk Based Post Marketing Surveillance (RB PMS) of Finished Medicinal Products
Latest News

pdf Guideline on Risk Based Post Marketing Surveillance (RB PMS) of Finished Medicinal Products

Download

Guideline on Risk-Based Post Marketing Surveillance (RB-PMS) of Finished Medicinal Products.pdf

Search Price

Publications

Newsletters

Citizen Charter

Laws and Policies

Blocklist Submission

Blocklist Verification

Blocklist Clearance

DGDA Notice Board

More News

© 2021 All rights reserved for Directorate General of Drug Administration.

Aushad Bhavan, Mohakhali, Dhaka-1212, Bangladesh

Tel : 8802 9880803, 9880864, 9880897, 9880924, Fax : 8802 9880854, E-mail : [email protected]

Display Date and Time

  • Last Modified: Wednesday 23 October 2024, 10:54:48.